June 18, 2026

  For millions of Americans living with depression, the search for effective treatment can feel like an uphill battle. However, two innovative treatments are generating significant clinical interest: Auvelity, an innovative oral antidepressant approved by the FDA in 2022, and ketamine, a rapid-acting therapy that has been transforming the treatment of depression for over two

Read More

June 12, 2026

  If you’ve been researching Transcranial Magnetic Stimulation (TMS) as a mental health treatment, you’ve probably come across a variety of device brand names and technical terms that can be difficult to understand. In this article, we clearly explain the benefits and uses of the most commonly used TMS devices, so you know what to

Read More

June 2, 2026

  Neurostimulation has become one of the most exciting frontiers in neuroscience, with techniques showing promise in treating various medical challenges, including mood disorders, neurodegenerative diseases, and chronic pain. In this article, we’ll take a look at the science and history of neurostimulation, and discuss why it is transforming the treatment of some of the

Read More

May 27, 2026

If you have been exploring ketamine as a treatment option for mental health disorders, you may have noticed that it comes in several different forms, intravenous (IV) and intramuscular (IM) injections, intranasal sprays and oral tablets. These different delivery methods can have hugely significant differences when it comes to unique drug effects, uses, how quickly

Read More

April 25, 2026

A Patient’s Guide to Accelerated TMS If you’ve been exploring TMS therapy, you may have come across accelerated TMS (aTMS). This guide breaks down what accelerated TMS is, how it compares to other TMS protocols, what the evidence shows, and whether this approach could be suitable for you. What is Accelerated TMS? Transcranial magnetic stimulation

Read More

April 18, 2026

Can Esketamine Enhance ECT? New Study Investigates Combined Treatment for Depression Traditional antidepressants don’t work for everyone struggling with depression, but new advanced treatments like esketamine (marketed as Spravato) offer hope. A recent clinical study investigated the effects of combining esketamine with electroconvulsive therapy (ECT). We’ll take a look at the study and its results

Read More